| cephalexin | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | 104fea5c-cb2a-16c3-e054-00144ff88e88 | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN | 6 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 3 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 5 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | c6d56d5e-856e-4e48-85f7-fce2beade4d1 | 4 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES USP | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 3 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 6 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN FOR AUROBINDO | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES USP | 2 | |
| Cephalexin | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | eac25cfc-92cb-411c-b109-25731815b936 | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN FOR ORAL SUSPENSION, USP Rx only | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN FOR ORAL SUSPENSION USP | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES USP | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN FOR ORAL SUSPENSION, USP Rx only | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP | 5 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules and other antibacterial drugs, cephalexin capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN - 500 MG - CAPSULES | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES USP | 3 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 3 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN FOR ORAL SUSPENSION USP | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsule | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES USP | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | b5da860d-9cfc-4020-bc81-11f2a01e660b | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL Rx only | 1 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL Rx only | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only | 1 | |
| Cephalexin | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN FOR ORAL SUSPENSION USP | 3 | |
| Cephalexin | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN FOR ORAL SUSPENSION USP | 3 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 4 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 4 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg Rx only | 1 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg Rx only | 1 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | d9a049bd-2161-4a9b-8f6d-0c7d2bfdb0ed | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | 13831529-e814-4b95-9287-c5ba6678bf52 | 2 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | 13831529-e814-4b95-9287-c5ba6678bf52 | 2 | |
| Cephalexin | ACTIVE INGREDIENT | OBN7UDS42Y | Cephalexin Capsules, USP | 1 | |
| Cephalexin | ACTIVE MOIETY | OBN7UDS42Y | Cephalexin Capsules, USP | 1 | |
| cephalexin | ACTIVE MOIETY | OBN7UDS42Y | KEFLEX ® CAPSULES CEPHALEXIN, USP | 1 | |
| cephalexin | ACTIVE INGREDIENT | OBN7UDS42Y | KEFLEX ® CAPSULES CEPHALEXIN, USP | 1 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3096 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3096 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN (CEPHALEXIN) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 22 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 21 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 18 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] | 11 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 10 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | KEFLEX (CEPHALEXIN) CAPSULE [SHIONOGI INC.] | 10 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN POWDER, FOR SUSPENSION [ORCHIDPHARMA INC] | 9 | |
| Cephalexin | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [CARLSBAD TECHNOLOGY, INC.] | 8 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN (CEPHALEXIN) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 7 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED] | 6 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 6 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULE [BELCHER PHARMACEUTICALS, LLC] | 5 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [BELCHER PHARMACEUTICALS, LLC] | 5 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] | 5 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN SUSPENSION [WEST-WARD PHARMACEUTICAL CORP] | 5 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [AVKARE, INC.] | 4 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 4 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 4 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] | 4 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [NORTHWIND PHARMACEUTICALS] | 3 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] | 3 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] | 3 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [AVPAK] | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [DIRECT RX] | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [GEN-SOURCE RX] | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PROFICIENT RX LP] | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [PROFICIENT RX LP] | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [VIRTUS PHARMACEUTICALS, LLC] | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN POWDER, FOR SUSPENSION [PROFICIENT RX LP] | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN TABLET [NORTHWIND PHARMACEUTICALS, LLC] | 2 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | FISH FLEX (CEPHALEXIN) CAPSULE [THOMAS LABS, LLC] | 2 | |
| cephalexin | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [AMERICAN HEALTH PACKAGING] | 1 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULE [GEN-SOURCE RX] | 1 | |